Literature DB >> 2680633

[Effects of neuromedin B and neuromedin C on insulin release from isolated perfused rat pancreas].

T Nakamura1, M Otsuki, Y Okabayashi, M Fujii, S Tani, T Oka, T Fujisawa, S Baba.   

Abstract

Neuromedin B and neuromedin C are novel decapeptides that have recently been isolated from porcine spinal cord and canine intestinal mucosa. We have studied the effects of neuromedin B and neuromedin C on insulin release from the isolated perfused rat pancreas. The effect of neuromedin B was detectable at a concentration of 10mM, and that of neuromedin C was detectable at a concentration of 1nM. Further increase in the concentration of neuromedin B and neuromedin C resulted in dose-dependent increases in insulin secretion. The effectiveness of neuromedin B and neuromedin C as insulinotropic agents depended on the glucose concentration; both were more effective at a higher concentration of glucose. However, insulinotropic effects of these peptides in the presence of 8.3mM glucose were limited to the first 3 min of a 20-min perfusion. These results, coupled with a recent study demonstrating bombesin-like immunoreactivity in nerves in the pancreas, suggest that neuromedin B and neuromedin C exert a direct local action on insulin secretion in the pancreas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680633     DOI: 10.1507/endocrine1927.65.8_695

Source DB:  PubMed          Journal:  Nihon Naibunpi Gakkai Zasshi        ISSN: 0029-0661


  1 in total

1.  Neuropeptide Neuromedin B does not alter body weight and glucose homeostasis nor does it act as an insulin-releasing peptide.

Authors:  Domagoj Cikes; Patricio Atanes; Shane J F Cronin; Astrid Hagelkrüys; Guo-Cai Huang; Shanta J Persaud; Josef M Penninger
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.